Protara Therapeutics, Inc.

NASDAQ:TARA

2.89 (USD) • At close July 3, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q3
Omzet 000001.2080000000000000000000000000000000000002.948
Kosten van de omzet 0000.0830.0830.1070.1070.420.0770.0740.0640.3950.397000.0550.03200000000000000000000000000
Brutowinst 000-0.083-0.0831.101-0.107-0.42-0.077-0.074-0.064-0.395-0.39700-0.055-0.03200000000000000000000000002.948
Brutowinstmarge 000000.9110000000000000000000000000000000000001
Onderzoek- en ontwikkelingskosten 9.1489.4998.076.3877.6656.3816.2187.2475.1434.9893.4663.0845.2694.0684.0935.8877.043.6512.7962.473.065-3.1851.0990.9871.0781.1092.3542.764.073.2110.343.894.254.444.845.244.353.583.083.092.631.871.773
Algemene en administratieve kosten 4.9764.8134.264.2744.1034.664.4824.8934.5895.0034.5085.6215.6056.2196.7376.9056.545.3055.2664.7967.0950.631.2550.4420.450.2982.2682.242.292.381.972.12.232.432.322.612.472.6121.891.991.41.041
Verkoop- en marketingkosten 00004.099-0.10700000000000000000000000.01000000.0100000000
Verkoop-, algemene en administratieve kosten 4.9764.8134.264.2744.1034.5534.4824.8934.5895.0034.5085.6215.6056.2196.7376.9056.545.3055.2664.7967.0950.631.2550.4420.450.2982.2682.242.32.381.972.12.232.432.332.612.472.6121.891.991.41.041
Overige kosten 00000000029.517000000000000000000000000000000000
Bedrijfskosten 14.12414.31212.3310.66111.76810.93410.712.149.7329.9927.9748.70510.87410.28710.8312.79213.588.9568.0627.26610.16-2.5552.3541.4291.5281.4074.62256.375.5912.315.996.486.877.177.856.826.195.084.984.623.272.814
Bedrijfsresultaat -14.124-14.312-12.33-10.661-11.851-11.041-10.7-12.14-9.73220.474-7.974-8.705-10.874-10.287-10.83-12.792-13.58-8.956-8.062-7.266-10.162.555-2.354-1.429-1.528-1.407-4.622-5-6.37-5.59-12.31-5.99-6.48-6.87-7.17-7.85-6.82-6.19-5.08-4.98-4.62-3.270.134
Bedrijfsresultaat ratio 00000-9.140000000000000000000000000000000000000.045
Totaal overige inkomsten en kosten netto 2.211.5431.1111.1480.7560.820.840.8460.6870.5420.2830.1660.1190.0590.0530.010.1150.1490.0920.1260.10.0300000.1120.120.290.04-6.7440.38-0.02-0.090.06-0.060.27-0.15-0.3-0.090.0410.5-7.592
Inkomen voor belasting -11.914-12.769-11.219-9.513-11.095-10.221-9.86-11.294-9.045-38.966-7.691-8.539-10.755-10.228-10.777-12.782-13.465-8.808-7.97-7.14-10.062.585-2.354-1.429-1.528-1.407-4.51-4.88-6.08-5.55-12.31-5.61-6.5-6.96-7.11-7.91-6.55-6.34-5.38-5.07-4.587.23-7.458
Inkomen voor belasting ratio 00000-8.461000000000000000000000000000000000000-2.53
Belastingkosten 00000.041.64-0.107-0.846-0.687-0.107-0.283-0.346-0.1191.9740.0240000.0210.02-0-0.0310.735-3.9080.2110.2510.2250.230.380.14-6.6680.430.01-0.050.11-0.010.33-0.12-0.27-0.050.0810.5130
Nettowinst -11.914-12.769-11.219-9.513-11.095-10.221-9.86-11.294-8.358-38.859-7.408-8.193-10.636-10.228-10.777-12.782-13.465-8.808-7.97-7.14-10.062.585-2.354-1.429-1.528-1.407-4.51-4.88-6.08-5.55-12.31-5.61-6.5-6.96-7.11-7.91-6.55-6.34-5.38-5.07-4.587.23-7.458
Nettowinstmarge 00000-8.461000000000000000000000000000000000000-2.53
WPA (Winst Per Aandeel) -0.29-0.59-0.5-0.45-0.97-0.9-0.87-1-0.74-3.45-0.66-0.73-0.95-0.91-0.96-1.14-1.2-0.79-1.26-1.22-1.81-0.29-0.92-0.56-0.58-0.12-10.12-11.09-13.82-12.61-27.98-13.05-15.48-16.98-17.34-19.29-15.98-15.46-13.12-12.37-11.1723.32-21.78
Verwaterde WPA -0.29-0.59-0.5-0.45-0.97-0.9-0.87-1-0.74-3.45-0.66-0.73-0.95-0.91-0.96-1.14-1.2-0.78-1.26-1.22-1.81-0.29-0.92-0.56-0.58-0.12-10.12-11.09-13.82-12.61-27.98-13.05-15.48-16.98-17.34-19.29-15.98-15.46-13.12-12.37-11.1723.32-21.78
EBITDA -14.124-14.23-12.246-10.578-11.768-10.934-10.621-12.062-9.655-38.786-7.353-7.798-10.358-10.233-10.777-12.727-13.433-8.892-8.035-7.126-10.112.834-1.5910-6.637-5.463-4.488-4.85-6.049-5.518-12.269-5.571-6.458-6.926-7.072-7.854-6.819-6.22-5.082-4.981-4.627.2530.134
EBITDA ratio 00000-9.0510000000000000000000000000000000000000.045